MaronBJTowbinJAThieneG. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816.
2.
SwedbergKClelandJDargieH. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-1140.
3.
EpsteinAEDiMarcoJPEllenbogenKA. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1-e62.
4.
LittmannLSymanskiJD. Hemodynamic implications of left bundle branch block. J Electrocardiol. 2000;33(suppl): 115-121.
5.
KerwinWFBotvinickEHO’ConnellJW. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol. 2000;35:1221-1227.
6.
NelsonGSBergerRDFeticsBJ. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053-3059.
7.
ClelandJGDaubertJCErdmannE. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
MossAJHallWJCannomDS. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338.
10.
RickardJWilkoffBL. Pivotal trials of cardiac resynchronization therapy: evolution to therapy in mild heart failure. J Interv Card Electrophysiol. 2011;31:61-68.
11.
EllenbogenKAMWilkoffBLKayGNLauCP. Clinical cardiac pacing, defibrillation, and resynchronization therapy. 2011, Saunders. pp. 279-300.
12.
Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
13.
BristowMRSaxonLABoehmerJ. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
14.
ClelandJGDaubertJCErdmannE. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
15.
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias: the Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576-1583.
16.
SiebelsJKuckKH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994;127:1139-1144.
17.
ConnollySJHallstromAPCappatoR. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator Study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-2078.
18.
BuxtonAELeeKLFisherJDJosephsonMEPrystowskyENHafleyG. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med. 1999;341:1882-1890.
19.
BernsteinADDaubertJCFletcherRD. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol. 2002;25:260-264.
20.
CrossleyGHPooleJERoznerMA. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients With Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: facilities and patient management:Heart Rhythm. 2011;8:1114-1154.
21.
JacobSPanaichSSMaheshwariR. Clinical applications of magnets on cardiac rhythm management devices. Europace. 2011;13:1222-1230.
22.
HallEH. On a new action of the magnet on electric currents. Am J Math. 1879;2:287-292.
23.
LevineGNGomesASAraiAE. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College Of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116:2878-2891.
24.
JungWZverevaVHajrediniBJackleS. Safe magnetic resonance image scanning of the pacemaker patient: current technologies and future directions. Europace. 2012;14:631-637.
25.
NazarianSHalperinHR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm. 2009;6:138-143.
26.
WilkoffBLBelloDTaborskyM. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. 2011;8: 65-73.
27.
ApfelbaumJLBelgottPConnisRT. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices. Anesthesiology. 2011;114: 247-261.
